Spain – Pharmaceutical products – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib

1 days left

España – Productos farmacéuticos – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib

🇪🇸 SpainContracting authority: ICS - Gerència de compres

Estimated value

Not disclosed

Deadline

Jul 10, 2026

Published

Jun 19, 2026

Procedure

Open

CS/CC00/1101472323/26/AM: Acuerdo marco para el suministro agregado de medicamentos Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib para los centros del l'Institut Català de la Salut y centros adheridos: Hospital del Mar de Barcelona, Sant Joan de Reus-Baix Camp, Hospital de Cerdanya – AECT Agrupació Europea de Cooperació Territorial, Institut d'Assistència Sanitària i Gestió de Serveis Sanitaris

Description shown in the original language of the notice.

CPV classification

33600000 — Pharmaceutical products

Official notice ↗

📊 Contracts in Medical equipments, pharmaceuticals and personal care products typically receive 3.7 bids. (2,522 contracts analysed)

🔒 Know the winning price before you bid: typical awarded vs. estimated value for this sector — with Pro. Upgrade to Pro →

🔔 Never miss a tender like this

Get new Medical equipments, pharmaceuticals and personal care products tenders in Spain in your inbox — free.

Create free alert →